Browsing: over

Novo Nordisk ($NVO) filed a lawsuit against Eli Lilly ($LLY), alleging Lilly’s advertising for Zepbound and Mounjaro relies on outdated clinical comparisons that understate the performance of Novo’s latest higher-dose Wegovy and Ozempic treatments. Novo is seeking to halt the advertising, require corrective marketing, and recover damages as the companies compete in the growing obesity…

Shop TODAY Beauty Awards: 120 Editor-Tested Products That Made the Cut Novo Nordisk Sues Eli Lilly Over Weight Loss Drug Advertisement July 21, 202602:08 $1 Billion up for Grabs as Mega Millions and Powerball Prizes Soar 00:37 Now Playing Novo Nordisk Sues Eli Lilly Over Weight Loss Drug Advertisement 02:08 UP NEXT Hundreds Gather to…